Table 6 Enriched terms in the profiling analysis of no-SCD patients, not identified in the SCD patients
Acc | Name | p-value | p-Bonf | SFreq | PFreq |
|---|---|---|---|---|---|
Biological process | |||||
GO:0001980 | Regulation of systemic arterial blood | 6.0E-41 | 4.4E-39 | 13% | 0.00 |
pressure by ischemic conditions | |||||
GO:0001976 | Neurological system process involved in regulation | 3.4E-25 | 2.5E-23 | 13% | 0.00 |
of systemic arterial blood pressure | |||||
GO:0006940 | Regulation of smooth muscle contraction | 6.6E-19 | 4.9E-17 | 13% | 0.00 |
GO:0007522 | Visceral muscle development | 5.3E-03 | 3.9E-01 | 1% | 0.00 |
GO:0042694 | Muscle cell fate specification | 5.3E-03 | 3.9E-01 | 1% | 0.00 |
GO:0055009 | Atrial cardiac muscle tissue morphogenesis | 2.6E-02 | 1.9E+00 | 1% | 0.00 |
GO:0003228 | Atrial cardiac muscle tissue development | 2.6E-02 | 1.9E+00 | 1% | 0.00 |
GO:0048739 | Cardiac muscle fiber development | 4.2E-02 | 3.1E+00 | 1% | 0.00 |
GO:0042693 | Muscle cell fate commitment | 5.7E-02 | 4.2E+00 | 1% | 0.00 |
Molecular function | |||||
GO:0031014 | Troponin T binding | 9.9E-33 | 7.3E-31 | 13% | 0.00 |
GO:0019855 | Calcium channel inhibitor activity | 1.9E-31 | 1.4E-29 | 13% | 0.00 |
GO:0008200 | Ion channel inhibitor activity | 1.4E-23 | 1.0E-21 | 13% | 0.00 |
GO:0016248 | Channel inhibitor activity | 1.4E-23 | 1.0E-21 | 13% | 0.00 |
GO:0005246 | Calcium channel regulator activity | 4.9E-23 | 3.6E-21 | 13% | 0.00 |
GO:0048306 | Calcium-dependent protein binding | 1.1E-19 | 8.1E-18 | 13% | 0.00 |
GO:0042805 | Actinin binding | 5.6E-06 | 4.2E-04 | 4% | 0.00 |
GO:0030899 | Calcium-dependent ATPase activity | 1.6E-02 | 1 | 1% | 0.00 |
GO:0003785 | Actin monomer binding | 7.2E-02 | 1 | 1% | 0.00 |